Since activin A promotes secretion of insulin from cultured pancreatic islet cells [125] and since elevated follistatin expression markedly increases insulin sensitivity in mouse skeletal muscle in vivo [126], it is possible that activation of the activin/inhibin/follistatin axis improves insulin responsiveness and glucose metabolism in COVID-19 patients. This evidence concerns the gene INS and COVID-19.